These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12382312)

  • 1. Orlistat-induced cutaneous leukocytoclastic vasculitis.
    Gonzalez-Gay MA; Garcia-Porrua C; Lueiro M; Fernandez ML
    Arthritis Rheum; 2002 Oct; 47(5):567. PubMed ID: 12382312
    [No Abstract]   [Full Text] [Related]  

  • 2. Orlistat-induced bullous leukocytoclastic vasculitis.
    Lazic T; Fonder M; Robinson-Bostom L; Wilkel CS; Della Torre L
    Cutis; 2013 Mar; 91(3):148-9. PubMed ID: 23617088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orlistat and obesity: be aware of lichenoid drug eruption.
    Koca Kalkan I; Kalpaklioglu AF; Atasoy P; Karabulut AA
    Eur J Dermatol; 2011; 21(3):456-7. PubMed ID: 21680292
    [No Abstract]   [Full Text] [Related]  

  • 4. Depression induced by orlistat (Xenical).
    Benazzi F
    Can J Psychiatry; 2000 Feb; 45(1):87. PubMed ID: 10696499
    [No Abstract]   [Full Text] [Related]  

  • 5. Zidovudine-induced leukocytoclastic vasculitis.
    Torres RA; Lin RY; Lee M; Barr MR
    Arch Intern Med; 1992 Apr; 152(4):850-1. PubMed ID: 1558446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous leukocytoclastic vasculitis in relation to streptokinase.
    Bindels AJ; See TL; Peters WG
    Neth J Med; 1992 Feb; 40(1-2):76-9. PubMed ID: 1579189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocytoclastic vasculitis related to rofecoxib.
    Palop-Larrea V; Melchor-Penella MA; Ortega-Monzó C; Martínez-Mir I
    Ann Pharmacother; 2003 Nov; 37(11):1731-2. PubMed ID: 14565803
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological sheet. Orlistat, oral administration (Xenical, Alli). ].
    J Pharm Belg; 2009 Jun; (2):67-8. PubMed ID: 19739531
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors.
    Drago F; Brusati C; Desirello G; Cacciapuoti M; Rebora A
    J Am Acad Dermatol; 2004 Dec; 51(6):1029-30. PubMed ID: 15583611
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab-induced vasculitis: A case report and review of the medical published work.
    Kim MJ; Kim HO; Kim HY; Park YM
    J Dermatol; 2009 May; 36(5):284-7. PubMed ID: 19382999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orlistat.
    Nurs Times; 2006 May 2-8; 102(18):27. PubMed ID: 16703990
    [No Abstract]   [Full Text] [Related]  

  • 12. Azithromycin-induced leukocytoclastic vasculitis.
    Odemis E; Kalyoncu M; Okten A; Yildiz K
    J Rheumatol; 2003 Oct; 30(10):2292. PubMed ID: 14528532
    [No Abstract]   [Full Text] [Related]  

  • 13. Hexamethylene bisacetamide-induced cutaneous vasculitis.
    Rowinsky EK; McGuire WP; Anhalt GJ; Ettinger DS; Donehower RC
    Cancer Treat Rep; 1987 May; 71(5):471-4. PubMed ID: 3567971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab-induced leukocytoclastic vasculitis: a case report.
    Kandula P; Kouides PA
    Arch Dermatol; 2006 Feb; 142(2):246-7. PubMed ID: 16490860
    [No Abstract]   [Full Text] [Related]  

  • 15. The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.
    Perrio MJ; Wilton LV; Shakir SA
    Obesity (Silver Spring); 2007 Nov; 15(11):2712-22. PubMed ID: 18070762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin induced vasculitis.
    Gamboa PM; Tabar AI; Wong E
    Allergol Immunopathol (Madr); 1988; 16(1):53-5. PubMed ID: 3381715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinidine-induced vasculitis.
    Shalit M; Flugelman MY; Harats N; Galun E; Ackerman Z; Kopolovic J; Eliakim M
    Arch Intern Med; 1985 Nov; 145(11):2051-2. PubMed ID: 4062457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orlistat associated with hypertension.
    Persson M; Vitols S; Yue QY
    BMJ; 2000 Jul; 321(7253):87. PubMed ID: 10884258
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety profile of orlistat: results of a prescription-event monitoring study.
    Acharya NV; Wilton LV; Shakir SA
    Int J Obes (Lond); 2006 Nov; 30(11):1645-52. PubMed ID: 16552401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lichenoid eruption associated with orlistat.
    Sergeant A; Milne G; Shaffrali F
    Br J Dermatol; 2006 May; 154(5):1020-1. PubMed ID: 16634924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.